Loratadine Market Report Overview
- Request a Free sample to learn more about this report
The global loratadine market size was expected to be worth USD 141.9 million in 2022 and market is projected to touch USD 197.09 million by 2031, exhibiting a compound annual growth rate (CAGR) of 3.3% during the forecast period.
This medication, sold under the brand name Claritin and others, is used to treat allergies. It has anti-allergic properties but does not cause sedation. It is an antagonist of the piperidine histamine H1 receptor. It is approved by the FDA for treating allergic rhinitis and urticaria. Among other allergies, it temporarily relieves hay fever symptoms including allergic reactions to pollen, dust, or other substances. In addition to sneezing and runny noses, you may also experience itchy throats, eyes, and noses. Hives can also be treated with loratadine by treating itching and redness. This drug, however, does not prevent hives or other allergic skin reactions. The medication including this medicine are antihistamines. Histamine, a substance in the body that causes allergic symptoms, is blocked by it. The second generation antihistamine is used to treat allergic rhinitis. In many clinical situations, loratadine and other second generation antihistamines are preferred over their first generation counterparts because of a lack of sedative and CNS effects.
Changes in lifestyle, allergies, and hypersecretion of histamine are the major drivers of the loratadine market. As allergy incidences increase and research and development projects in allergies expand, the market is growing. Additionally, the growing usage of this drug in various types of allergies will boost market growth during the forecast period. Loratadine market growth is also expected to be driven by continuous development of the drug. Based on the aforementioned factors, the market is expected to grow over the forecast period. The market's growth is however hindered by side effects and the availability of alternatives to this medicine.
COVID-19 Impact: Halt on Chemicals and Advanced Materials to Hamper Market
The COVID-19 outbreak has had a negative impact on the global economy, bringing various sectors to a halt. Healthcare was significantly impacted by the COVID-19 outbreak. Numerous end-user industries have halted production due to the spread of the Coronavirus. In turn, this has led to a decline in the demand for chemicals used in these facilities. Even though the sudden lockdown and restrictions imposed by the government due to the pandemic outbreak had affected the import and export of the drugs, these drugs including loratadine had a positive impact in the market. Since the cases of COVID-19 increased, infections like cough, sneezing, and watery eyes also increased which increased the demand for anti-histamine drugs, mainly loratadine due to the less side effects of the same drug compared to other medicines.
Latest Trends
"Continuous Development of Drugs to Drive the Market"
The entire process of bringing a new drug or device to market is called drug development. Development of drugs is expanding these days, and the usage of loratadine as well. The increase of allergic reactions in a larger population is forcing the pharmaceutical industry to develop more anti-histamine drugs. Continuous development of drugs also affects the pharmaceutical industry, thereby driving the pharmaceutical industry as well.
Loratadine Market Segmentations
- Request a Free sample to learn more about this report
- By Type
The market is classified into USP standards grade, EP standards grade, pharmaceutical standards grade, and others based on type. The USP standards grade will lead the kitchen tools market share throughout the forecast period.
- By Application
The market is classified into loratadine tablet, loratadine capsules, loratadine syrup, and others on the basis of application. The loratadine tablet segment will lead the kitchen tools market share throughout the forecast period.
Driving Factors
"Increasing Usage of Loratadine Tablets to Drive the Market"
The market share of this tablet is expected to grow significantly due to the availability of large, approved tablet forms and ease of administration. In the treatment of cough and allergies, the drug is used with other medications such as pseudoephedrine, ambroxol, and others. Capsules usually have a shorter shelf life than tablets, which are durable, long-lasting, stable, and have a longer shelf life. An active ingredient can be contained in a tablet in a greater quantity than in a capsule. So, the demand for this tablets increases, thereby driving the loratadine market growth.
"Usage of Loratadine to Cure Other Diseases to Drive the Market"
Apart from treating allergies, it also has various other benefits including the usage of this drug to reduce the itching effect due to Kimura’s disease. There is no cure for Kimura's disease, which is a chronic inflammatory disorder that is benign. It is characterized by painless unilateral inflammation of the cervical lymph nodes or subcutaneous lesions in the head or neck.
Restraining Factors
"Side Effects Caused by Loratadine to Drive the Market"
Heart issues caused due to this medicine is one of the restraining factors of the market. In patients with heart problems, it can cause fast or irregular heartbeats and palpitations. It should be taken with caution by patients with heart disease.
Loratadine Market Regional Insights
- Request a Free sample to learn more about this report
"North America to Lead the Market Share Owing to it’s Well-Established Healthcare"
There is a high prevalence of allergies in the North American region, which is predicted to increase North America's growth rate due to its well-established healthcare infrastructure, the presence of key market players who manufacture and market this tablet, and its well-established healthcare infrastructure. A growing adaptation of this medicine and active pipelines are also expected to boost regional growth. The Asthma and Allergy Foundation of America consider approximately 25 metropolitan areas high-risk for allergy attacks in the 2022 report.
Asia Pacific holds the second largest share of the market due to the developing and high-class infrastructure of the medical field. The high number of market players also is a major factor that accounts to the loratadine market share of the region.
Key Industry Players
"Key Players Focus on Partnerships to Gain a Competitive Advantage "" "
Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.
List of Market Players Profiled
- Merck (U.S.)
- Cadila Pharmaceuticals (India)
- Morepen (India)
- Ultratech India (India)
- Vasudha Pharma Chem (India)
- Hetero Drugs (India)
- Mylan (U.S.)
- Changzhou Yabang (China)
- Shaanxi Hanjiang (China)
- Inke, S.A. (Spain)
- Argon Drugs (India)
Report Coverage
This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of loratadine market dynamics change.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 141.9 Million in 2022 |
Market Size Value By |
US$ 197.09 Million by 2031 |
Growth Rate |
CAGR of 3.3% from 2022 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What value is the Loratadine Market expected to touch by 2031?
The Loratadine Market is expected to reach a value of USD 197.09 million by 2031.
-
What CAGR is the Loratadine Market expected to exhibit by 2031?
The Loratadine Market is expected to exhibit a CAGR of 3.3% by 2031.
-
Which are the driving factors of the Loratadine Market?
Increasing usage of loratadine tablets, and usage of loratadine to cure other diseases are some of the major driving factors of the Loratadine Market.
-
Which are the top companies in the Loratadine Market?
The top companies in the market include Morepen, Merck Group, Ultratech India Limited, Vasudha Pharma Chem, etc.